Yoshihiko Ōsaki

Recent publications · Crossref

5 total works indexed

1. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

   · 2015 · cited 4,973x

2. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

   · 2018 · cited 3,970x

3. Donanemab in Early Symptomatic Alzheimer Disease

   · 2023 · cited 2,412x

4. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

   · 2019 · cited 1,616x

5. Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

   · 2021 · cited 1,574x

via Crossref · CC0

Wikidata facts

Image

Yoshihiko Osaki 1960.jpg